<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82053">
  <stage>Registered</stage>
  <submitdate>30/05/2007</submitdate>
  <approvaldate>4/06/2007</approvaldate>
  <actrnumber>ACTRN12607000293460</actrnumber>
  <trial_identification>
    <studytitle>Randomised trial of Ablation vs no Ablation of Barrett's oesophagus with Argon Plasma Coagulation in patients who have not undergone surgery for reflux</studytitle>
    <scientifictitle>Randomised trial of Ablation vs no Ablation of Barrett's oesophagus with Argon Plasma Coagulation in patients who have not undergone surgery for reflux</scientifictitle>
    <utrn />
    <trialacronym>Argon Plasma Coagulation medical trial</trialacronym>
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Barrett's oesophagus</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Oesophageal (gullet)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention entails coagulating the distal oesophageal mucosa at endoscopy with argon plasma coagulation to try to force conversion of a metaplastic columnar mucosa back to a squamous mucosa. </interventions>
    <comparator>Both the study and control groups are then managed by standard clinical care - ie yearly endoscopy with mucosal biopsies to identify early cancer development in the oesophagus.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>We are determining the outcome at each year of follow-up.</outcome>
      <timepoint>Endoscopy is being undertaken yearly and patients will be followed for 20 years.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Endoscopy is being undertaken yearly and patients will be followed for 20 years.</outcome>
      <timepoint>We are determining the outcome at each year of follow-up.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Presence of Barrett's oesophagus at endoscopy, reflux controlled by proton pump inhibitor medication. </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Reflux controlled by fundoplication.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelope opened in endoscopy room</concealment>
    <sequence>120 Envelopes prepared by independent nurse (60 = treatment, 60=control), and shuffled extensively.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>2 groups - 1 receives standard treatment - regular endoscopy surveillance, and one receives ablation followed by endoscopy surveillance</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2000</anticipatedstartdate>
    <actualstartdate>4/04/2001</actualstartdate>
    <anticipatedenddate />
    <actualenddate>1/01/2005</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize>65</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/01/2020</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>The Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>Flinders Medical Centre - Bedford Park</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Dept of Surgery, Flinders University</primarysponsorname>
    <primarysponsoraddress>Bedford Park, SA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Department of Surgery, Flinders University</fundingname>
      <fundingaddress>Bedford Park, SA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Dept of Surgery, Adelaide University</sponsorname>
      <sponsoraddress>Adelaide</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Comparison of Argon plasma Coagulation with surveillance for the reversal of Barrett's oesophagus  and the prevention of cancer in the oesophagus, in patients who are taking conventional medications for gastroesophageal reflux</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Flinders Medical Centre</ethicname>
      <ethicaddress />
      <ethicapprovaldate>18/08/2003</ethicapprovaldate>
      <hrec>1/034</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>21/11/2000</ethicapprovaldate>
      <hrec>990308</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Professor David Watson</name>
      <address>Department of Surgery
Flinders Medical Centre
Bedford Park SA 5042</address>
      <phone>+61 8 82046086</phone>
      <fax>+61 8 82046130</fax>
      <email>david.watson@flinders.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Professor David Watson</name>
      <address>Department of Surgery
Flinders Medical Centre
Bedford Park
SA 5042</address>
      <phone>+61 8 82046086</phone>
      <fax>+61 8 82046130</fax>
      <email>david.watson@flinders.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>David Watson</name>
      <address>Dept Surgery
Flinders University</address>
      <phone>+61882046086</phone>
      <fax />
      <email>david.watson@flinders.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>